Literature DB >> 24448101

Treatment of severe postRYGB hyperinsulinemic hypoglycemia with pasireotide: a comparison with octreotide on insulin, glucagon, and GLP-1.

Loek J M de Heide1, Anke J Laskewitz2, Jan A Apers3.   

Abstract

Entities:  

Keywords:  GLP-1; Glucagon; Hyperinsulinemic hypoglycemia; Octreotide; Pasireotide; Roux-en-Y gastric bypass

Mesh：

Substances：

Year:  2013        PMID： 24448101     DOI： 10.1016/j.soard.2013.11.006

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN： 1550-7289            Impact factor:   4.734


× No keyword cloud information.
  9 in total

1.  A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals.

Authors:  Caroline C Øhrstrøm; Dorte L Hansen; Urd Lynge Kielgast; Bolette Hartmann; Jens Juul Holst; Dorte Worm
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

2.  Post-Gastric Bypass Hyperinsulinemic Hypoglycemia: Fructose is a Carbohydrate Which Can Be Safely Consumed.

Authors:  Anne E Bantle; Qi Wang; John P Bantle
Journal:  J Clin Endocrinol Metab       Date:  2015-06-02       Impact factor: 5.958

3.  Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case Report.

Authors:  Verena Schwetz; Karl Horvath; Patrizia Kump; Carolin Lackner; Aurel Perren; Flavio Forrer; Thomas R Pieber; Gerlies Treiber; Harald Sourij; Julia K Mader
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Clinical practice guidelines for congenital hyperinsulinism.

Authors:  Tohru Yorifuji; Reiko Horikawa; Tomonobu Hasegawa; Masanori Adachi; Shun Soneda; Masanori Minagawa; Shinobu Ida; Takeo Yonekura; Yoshiaki Kinoshita; Yutaka Kanamori; Hiroaki Kitagawa; Masato Shinkai; Hideyuki Sasaki; Masaki Nio
Journal:  Clin Pediatr Endocrinol       Date:  2017-07-27

5.  Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion.

Authors:  Alexia Rouland; Benjamin Bouillet; Pauline Legris; Isabelle Simoneau; Jean-Michel Petit; Bruno Vergès
Journal:  Clin Pharmacol       Date:  2021-02-05

Review 6.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565

Review 7.  Somatostatin receptors in congenital hyperinsulinism: Biology to bedside.

Authors:  Mirjam E van Albada; Klaus Mohnike; Mark J Dunne; Indi Banerjee; Stephen F Betz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055

Review 8.  Congenital hyperinsulinism: current status and future perspectives.

Authors:  Tohru Yorifuji
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-06-30

9.  Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation.

Authors:  Christiaan F Mooij; Carline E Tacke; Mirjam E van Albada; Winfried Barthlen; Hennie Bikker; Klaus Mohnike; Matthijs W N Oomen; A S Paul van Trotsenburg; Nitash Zwaveling-Soonawala
Journal:  Ann Pediatr Endocrinol Metab       Date:  2021-05-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.